Blending Treatments Worldwide for Multiple Myeloma

David S. Siegel, MD, PhD

Video Categories: Hematological Malignancies

David S. Siegel, MD, PhD, at the John Theurer Cancer Center in Hackensack, NJ, explains the benefits of worldwide clinical trials in creating more consistent, less toxic treatment options for multiple myeloma. New drugs are coming along, and the clinical trials for those drugs are beginning to mature.
July 29, 2015

Assessing the Value of Cancer Treatments

Dr. Steve O’Day believes a treatment’s value incorporates combination of benefits, side-effects, and cost, stating that if the cost is high, we need to make sure the benefits are huge as well.

October 14, 2013

PMO Interview with the Innovator Series: Volume 6

The publishers of Personalized Medicine in Oncology (PMO) invite you to watch an interview with Dr Lawrence Weiss, Medical Director at Clarient Diagnostic Services, discussing personalized medicine in diagnostics and with MultiOmyx™.